EDGAR Filing Documents for 0001193125-20-161012

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-20-161012

Filing Date

2020-06-05

Accepted

2020-06-04 21:20:05

Documents

Period of Report

2020-06-04

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	d935734d6k.htm	6-K	10495
2	EX-10.1	d935734dex101.htm	EX-10.1	685389
3	EX-10.2	d935734dex102.htm	EX-10.2	99315
4	EX-10.3	d935734dex103.htm	EX-10.3	254379
5	EX-10.4	d935734dex104.htm	EX-10.4	116163
6	EX-99.1	d935734dex991.htm	EX-99.1	20897
7	GRAPHIC	g935734dsp0230.jpg	GRAPHIC	2279
8	GRAPHIC	g935734dsp245a.jpg	GRAPHIC	6794
9	GRAPHIC	g935734dsp245b.jpg	GRAPHIC	2625
10	GRAPHIC	g935734dsp245jpg.jpg	GRAPHIC	6099
11	GRAPHIC	g935734dsp247.jpg	GRAPHIC	6637
12	GRAPHIC	g935734dsp247a.jpg	GRAPHIC	9339
13	GRAPHIC	g935734dsp247b.jpg	GRAPHIC	2944
	Complete submission text file	0001193125-20-161012.txt		1239277

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF

Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300

Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)